SCHEMBL14402994

SCHEMBL14402994

CCCCCCOc1cc(C2=NN(C(=O)c3ccc(NC(=O)c4cccnc4)cc3)CCC2)ccc1OC

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ AAK1 Q2M2I8 2/20 0.41
▸ SMPD1 P17405 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ PDE4B Q07343 2/20 0.41
▸ ABL1 P00519 2/20 0.41
▸ BCR P11274 2/20 0.41
▸ PDE4A P27815 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL144344 0.95 ABCB1 (0.45) ABCB1ABCG2MAPTALDH1A1POLB
SCHEMBL146879 0.92 MAPK1 (0.47) ABCB1ABCG2MAPTALDH1A1POLB
SCHEMBL147544 0.90 LMNA (0.51) ABCB1ABCG2MAPTALDH1A1POLB
Hydrochloric Acid SCHEMBL7650133 0.89 LMNA (0.50) ABCB1ABCG2MAPTALDH1A1POLB
SCHEMBL143145 0.85 ABL1 (0.51) ABCB1ABCG2MAPTALDH1A1POLB
SCHEMBL146882 0.85 MAPK1 (0.46) ABCB1ABCG2MAPTALDH1A1AAK1
Hydrochloric Acid SCHEMBL7652761 0.84 MAPK1 (0.45) ABCB1ABCG2MAPTALDH1A1AAK1
SCHEMBL145065 0.84 PDE4A (0.51) ABCB1ABCG2MAPTALDH1A1POLB
Hydrochloric Acid SCHEMBL7646226 0.84 PDE4D (0.50) ABCB1ABCG2MAPTALDH1A1POLB
SCHEMBL6603434 0.83 LMNA (0.50) ABCB1ABCG2ALDH1A1AAK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1849468-A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist Nycomed GmbH (DE) 2007-10-31 — — EP disclosed
Send feedback